Corcept Therapeutics, Inc. (CORT) Misses Q1 Loss views by 2c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $87.32 +3.03%
Revenue Growth %: +12.1%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +12.1%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q1 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- EU panel backs Hopledo for Parkinson's motor fluctuations
- Morgan Stanley Assumes Prada SpA (1913:HK) (PRDSY) at Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
